SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-025814
Filing Date
2022-07-08
Accepted
2022-07-08 16:05:20
Documents
2
Period of Report
2022-07-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1555
2 EX-24 DOCUMENT attachment1.htm EX-24 4540
  Complete submission text file 0000899243-22-025814.txt   7501
Mailing Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Issuer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address KYMERA THERAPEUTICS, INC. 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472
Business Address
Morgan Leigh (Reporting) CIK: 0001935887 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39460 | Film No.: 221074416